WHO says it suspends clinical trial with hydroxychloroquine on COVID-19 patients

WHO says it suspends clinical trial with hydroxychloroquine on COVID-19 patients

The WHO Director-General Tedros Adhanom Ghebreyesus says a clinical trial of malaria drug hydroxychloroquine on COVID-19 patients came to "a temporary pause," while the safety data is reviewed by the Data Safety Monitoring Board. #COVID19

WHO says it suspends clinical trial with hydroxychloroquine on COVID-19 patients
WHO pauses trial of hydroxychloroquine in Covid-19 patients
WHO suspends hydroxychloroquine trial for coronavirus patients due to safety concerns | ABC News
WHO suspends clinical trial of Hydroxychloroquine for COVID-19 Patients
WHO suspends hydroxychloroquine trial over safety concerns
WHO suspends testing of Hydroxychloroquine drug in COVID-19 patients over safety concerns
WHO SUSPENDS CLINICAL TRIALS OF HYDROXYCHLOROQUINE
WHO suspends trial of hydroxychloroquine as COVID-19 treatment over safety concerns
WHO suspends trial of hydroxychloroquine as COVID-19 treatment over safety concerns
WHO suspends trial of hydroxychloroquine as COVID 19 treatment over safety concerns
WHO suspends clinical trial of hydroxychloroquine for COVID-19
Hydroxychloroquine: WHO pauses Covid-19 clinical trial
HCQ trails suspended amid safety concerns | WHO | COVID-19 treatment
WHO suspends trial of hydroxychloroquine as COVID-19 treatment over safety concerns
WHO HALTS COVID-19 HYDROXYCHLOROQUINE TRIALS
COVID-19: W.H.O halts Hydroxychloroquine trials
Explained: Why WHO suspended hydroxychloroquine trials | Covid-19
Medical journal retracts study on hydroxychloroquine for Covid-19 treatment
W.H.O. pauses hydroxychloroquine from drug study, warns of possible "second peak" of coronavirus
Hydroxychloroquine trials halted, researchers focus on other COVID-19 treatments